Survey of Medical Liaison Practices across the Pharmaceutical Industry
- PDF / 138,853 Bytes
- 14 Pages / 612 x 792 pts (letter) Page_size
- 88 Downloads / 177 Views
457
Survey of Medical Liaison Practices Across the Pharmaceutical Industry
Christopher M. Marrone, PharmD Medical Liaison Consultant, Eli Lilly and Company, Indianapolis, Indiana J. Lynn Bass, PharmD Senior Regional Medical Liaison, Amgen Inc. Craig J. Klinger, RPh Senior Medical Liaison Consultant, Eli Lilly and Company, Indianapolis, Indiana
Key Words Medical liaison; Pharmaceutical industry; Field based; Employment; Survey; Benchmarking Correspondence Address Christopher M. Marrone, PharmD, 2452 North Talbott Street, Indianapolis, IN 46205 (e-mail: [email protected]). Data previously presented at the 41st Annual Drug Information Association Annual Meeting, Washington, DC, June 28, 2005.
Medical liaisons were initially established in the pharmaceutical industry in the late 1960s. Since that time, their role has been evolving in such a way that today medical liaisons are helping to improve outcomes for patients in a variety of venues. They accomplish this through the timely, responsive dissemination of medical information, by exploring mutual clinical and scientific interests with health care providers, by facilitating medical education, and through understanding the dynamics and unmet needs within therapeutic areas. In the literature, there are no recent, published benchmarking data available on medical liaison programs within the pharmaceutical industry. To fill this gap, we conducted a 29-question survey to gather information on 10 key categories of medical liaison programs. The areas for which we sought information included company demographics, med-
INTRODUCTION The mission of the medical liaison position is to contribute to improved outcomes for patients through the timely, responsive dissemination of medical information, by exploring mutual clinical and scientific interests with health care providers, by facilitating professional education, and through growth in understanding the dynamics and unmet needs within therapeutic arenas. To achieve this mission, medical liaisons develop and enhance relationships with key opinion leaders within the health care community. Key opinion leaders are those health care practitioners who are considered experts by their peers within their respective fields for their research, publications, speaking, or influence (1). Key opinion leaders have special needs as customers that cannot be met by sales representatives. The need for in-depth and cutting-edge information about products is foremost because these practitioners are in a position to design
ical liaison division background, individual medical liaison information, roles and responsibilities, client demographics, training, knowledge assessment, performance review/performance management, administrative tasks, and current challenges. The survey was sent to approximately 400 members of the Drug Information Association’s Medical Communications Special Interest Area Community. Instructions were provided requesting that the survey be filled out only by managers of medical liaison programs. We received 42 complete responses
Data Loading...
